Quick Dispatch:
Your glp 1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp 1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways ships.
Need Help?
Questions about glp 1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp 1 and ampk GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways in your area.
Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
22.80
AMPK: Metabolism & Insulin + Ways to Activate
26.12
Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling
22.58
Frontiers
28.06
The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease | Pharmacological Reports
23.39
GLP-1 Agonists: Dual Benefits for Diabetes and Cancer
23.57
Glucagon-Like Peptide-1 and Its Implications in Obesity
22.50
